Cargando…
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
Autores principales: | Dragičević, Ida Hude, Bašić-Kinda, Sandra, Dujmović, Dino, Radman, Ivo, Dreta, Barbara, Dotlić, Sandra, Galunić-Bilić, Lea, Dobrenić, Margareta, Kralik, Marko, Rončević, Pavle, Aurer, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621567/ http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb |
Ejemplares similares
-
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma
por: Premužić, Vedran, et al.
Publicado: (2023) -
P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
por: Santarsieri, Anna, et al.
Publicado: (2022) -
P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
por: Mocikova, Heidi, et al.
Publicado: (2022) -
P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
por: Dorokhina, Elena, et al.
Publicado: (2022) -
ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma
por: Amin, M. S. A., et al.
Publicado: (2020)